COP vs CSBR · P/E 19, rev $58.94B vs P/E 16, rev $56.9M
ConocoPhillips (COP) versus Champions Oncology Inc (CSBR) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
COP currently screens at market cap $135.49B and trailing P/E 18.8. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Not investment advice. Open the COP and CSBR stock pages for the full models.
Not investment advice.